GlucoTrack, Inc. (GCTK) Stock Analysis & Investment Frameworks
GlucoTrack, Inc. (GCTK) stock analysis on Invetso. Review GlucoTrack, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
GlucoTrack, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
GlucoTrack, Inc. Key Financial Metrics
- Market Cap: $2.04M
- Revenue: $N/A
- ROE: -2135.52%
- ROIC: 460.04%
- Dividend Yield: N/A
About GlucoTrack, Inc.
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
GlucoTrack, Inc. Investment Frameworks
Invetso analyzes GlucoTrack, Inc. (GCTK) across the following frameworks:
- GlucoTrack, Inc. 10Y Growth Potential
- GlucoTrack, Inc. Scenario Analysis
- GlucoTrack, Inc. Risks & Opportunities
- GlucoTrack, Inc. Economic Moat
- GlucoTrack, Inc. Business Model
- GlucoTrack, Inc. Management
- GlucoTrack, Inc. SWOT Analysis
- GlucoTrack, Inc. Porter's 5 Forces
- GlucoTrack, Inc. PESTLE Analysis
- GlucoTrack, Inc. ESG Analysis